AccelStor Debuting NeoSapphire All-Flash Array Series at GDPR in the Public Sector Conference
AccelStor, the software-defined all-flash array provider, will be demonstrating its NeoSapphire all-flash array products at the “GDPR in the Public Sector” Conference. NeoSapphire All-Flash arrays offer a worry-free and GDPR compliant storage solution. AccelStor’s software-defined storage platform provides both powerful performance and strong data protection capabilities assisting customers with heavy-load requirements to construct a secured IT infrastructure and ensure they are GDPR compliant. The NeoSapphire All-Flash Array will be on display at Old Trafford Stadium in Manchester, UK on November 8, 2017.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171101005006/en/
NeoSapphire series provides a worry-free all-flash storage solution that is fully GDPR compliant in terms of affected systems and software capabilities. (Photo: Business Wire)
The EU General Data Protection Regulations (GDPR) will take effect in May 2018 and will cover the European Union across all 28 EU members. It’s a new legal framework in the EU that aims to protect citizens regarding the possession and usage of personal data. In the UK, the requirement to be compliant will be unaffected by the planned exit from the EU in 2019.
AccelStor Vice President, David Kao, said “With the GDPR coming into effect, it’s becoming crucial for any organisation and enterprise to review their internal process of handling any personal, company or government data. This calls for a refresh of security and data protection policies as well as new efficient tools and storage platforms like NeoSapphire all-flash array.”
As demand for high performance computing grows from the trend of IOT, artificial intelligence and big data analysis, enterprises require ever more powerful IT infrastructure. Different from conventional disk arrays, generating around 400K IOPS with over 1000 hard disk drives, the NeoSapphire all-flash array (AFA) could present stunning performance with a market-leading 1 million IOPS using only 24 SSDs and utilizing only 2U of rack space*. The NeoSapphire product range, using the FlexiRemap® software technology, coupled with a shared-nothing architecture, provides a proven AFA platform for data integrity and data protection. AccelStor’s NeoSapphire high availability all-flash array products deliver 99.9999% reliability and enable comprehensive data protection across the enterprise. Furthermore, to ensure minimum RPO and RTO for IT operators, the NeoSapphire series also provides instant failover, space-efficient snapshots, snapshots backup and a worry-free active-active hardware design.
Handling personal data is the key for GDPR compliance. Steps must be taken to minimise the risk of personal identification and ensure that the data inventory is stored in a secure location and device. The data controller must conduct privacy impact assessments and implement technical measures within the GDPR principles. As an enterprise storage vendor with customers who will be within the GDPR scope, AccelStor can provide Self Encrypting Disk (SED) SSDs which provide storage level data protection and compliance with the “data at rest” section of the GDPR regulation.
Download the AccelStor
Learn more about the NeoSapphire all-flash array series
Learn more about FlexiRemap® Technology
Follow AccelStor on Twitter: @AccelStor
Follow AccelStor on Linkedin
About AccelStor, Inc.
AccelStor is accelerating the paradigm shift from conventional disk arrays to modern all-flash storage. AccelStor's NeoSapphire all-flash arrays, powered by FlexiRemap software technology, deliver sustained high IOPS for business-critical applications. With streamlined storage management, multi-protocol support, and front-access, hot-swappable solid-state drives, the NeoSapphire series promises to resolve performance bottlenecks for I/O-intensive applications like artificial intelligence, IoT, data center, virtualization, high-performance computing, database, media processing, fintech and gaming. For more information about AccelStor and NeoSapphire, please visit www.accelstor.com.
AccelStor, FlexiRemap and NeoSapphire are trademarks or registered trademarks of AccelStor, Inc. in the United States of America and/or other countries.
* IOPS test results mentioned in this press release are generated by AccelStor and may vary in different test environments.
Clara Lee, +886 2 77467616 ext. 2561
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 12:11 | Tiedote
The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other
Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 19:20 | Tiedote
Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to
Ncardia Announces Completion of €10.5M Investment Round17.11.2017 15:31 | Tiedote
Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h
Double Win for Vocalink at the 2017 Payments Awards17.11.2017 12:35 | Tiedote
Vocalink, a Mastercard company, was last night awarded with two prestigious awards - The Overall Winner and the Payments Infrastructure of the Year Award, for its leading technology and expertise, and in recognition for a milestone year that saw Vocalink’s solutions transform the way people and businesses move money across the globe. 2017 saw Vocalink deliver ground-breaking immediate payments solutions both in the US and Thailand as well as enabling access to the UK payments industry through their payments gateway solution PayPort. The business also saw the launch of the new image based cheque clearing system, creating a robust and more efficient system in the UK. RTP ® in the US: This week, Vocalink announced the launch of RTP® (Real-Time Payments) in the US on behalf of The Clearing House; one of the most comprehensive real-tim
Envion AG: Start-up from the Heart of Berlin Has Pioneered Decentralized Mobile Mining by Combining Blockchain with Regenerative Energy17.11.2017 12:00 | Tiedote
Envion AG has created a technology for the first truly mobile data-center that uses low-priced local energy to mine a broad spectrum of cryptocurrencies (Bitcoin, Ethereum, etc.). By harvesting locally available clean energy right at the source, envion can operate at lower costs than competitors and at the same time reduces the CO2 footprint of the blockchain industry. Envion aims at decentralizing the highly-concentrated mining market (China holds 80% in Bitcoin mining) and at bringing control of the market back to the users. That’s why envion gives 100% of its mining profits back to its community. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171117005011/en/ Envion - World's Most Profitable Standard of Self-Expanding Crypto Infrastructure (Photo: Business Wire) Current challenges in the energy
Chugai's HEMLIBRA® Receives the World's First Regulatory Approval from FDA for Hemophilia A with Inhibitors17.11.2017 02:30 | Tiedote
Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that the U.S. Food and Drug Administration (FDA) has approved the bispecific antibody emicizumab (US product name: HEMLIBRA®) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors. This represents the first regulatory approval for HEMLIBRA® around the world. The US Biologics License Application (BLA) was submitted by Genentech, a member of Roche Group. “We are pleased that HEMLIBRA, a biopharmaceutical created by Chugai scientists based on their exceptional idea, has received its first regulatory approval,” said Chugai’s President & COO, Tatsuro Kosaka. “HEMLIBRA is a first in class biopharmaceutical which is an advancement on the current limited treatment options available for pat
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme